The FDA’s outside vaccine advisers plan to convene Thursday to recommend which Covid-19 strain vaccine manufacturers should target for the 2026-2027 season’s products, all while the country’s vaccine ...
Hosted on MSN
FDA approves new breast cancer treatments, offering hope for early and late-stage patients
Three FDA breakthrough approvals for breast cancer treatments presented at the San Antonio Breast Cancer Symposium are ...
FDA Notice Warns Consumers About Recalled Parmesan Ranch Seasoning ...
As the FDA''s deputy commissioner for food, Diamantas, a former food and drug attorney, led the agency's Human Foods Program ...
MedPage Today on MSN
FDA's Vaccine Panel to Weigh XFG Variant for New COVID Shots
But advisors will take a hard look at "Cicada" variant as well ...
By Yasmeen Abutaleb, Emma Rumney and Chris Prentice WASHINGTON, May 26 (Reuters) - The U.S. FDA's new, looser regulation of ...
Phase 3 data support a lower age threshold for linaclotide, making it the first prescription therapy approved for functional constipation in patients ages 2 to 5.
Blackstone Products has voluntarily recalled three lots of its Parmesan Ranch seasoning product due to a potential salmonella ...
An FDA advisory panel is considering updating the 2026-2027 COVID vaccine. The updated vaccine would target the XFG ...
A Utah-based wholesaler voluntarily recalled a banana smoothie product after it was notified of a potential salmonella risk.
The FDA expanded its approval of linaclotide to include pediatric patients aged 2 to 5 years with functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results